Losses and gains: Chronic pain and altered brain morphology

Expert Review of Neurotherapeutics

Volumn 13, Issue 11, 2013, Pages 1221-1234

  Borsook, David ^a   Erpelding, Nathalie ^a   Becerra, Lino ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Antidepressants; Boutons; Brain; Connectivity; Cortex; Dendrites; Dendritic tree; FMRI; Opioids; Thalamus; Voxel based morphology

Indexed keywords

AMITRIPTYLINE; KETAMINE; METHADONE;

AGING; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; BRAIN; BRAIN CORTEX; BRAIN FUNCTION; BRAIN MORPHOLOGY; BRAIN SIZE; CEREBROVASCULAR ACCIDENT; CHRONIC PAIN; CINGULATE GYRUS; CROHN DISEASE; DENDRITE; DISEASE ASSOCIATION; DORSAL FRONTOMEDIAL CORTEX; DRUG DEPENDENCE; DRUG EFFECT; DRUG INDUCED HEADACHE; GRAY MATTER; HIPPOCAMPUS; HUMAN; INFERIOR FRONTAL GYRUS; INFLUENZA; INSULA; MAJOR DEPRESSION; META ANALYSIS (TOPIC); MIDDLE FRONTAL GYRUS; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NEUROANATOMY; NEUROBIOLOGY; NEUROPATHOLOGY; NOCICEPTION; PAIN THRESHOLD; PARACINGULATE CORTEX; PARAHIPPOCAMPAL GYRUS; PUTAMEN; REVIEW; SEX DIFFERENCE; SPINAL CORD INJURY; STRESS; SYNAPTOGENESIS; THALAMUS; WHITE MATTER;

BRAIN; CEREBRAL CORTEX; CHRONIC PAIN; HUMANS; NERVE FIBERS, MYELINATED; NERVE NET; PAIN MEASUREMENT;

EID: 84887271199     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2013.846218     Document Type: Review

References (178)

1. Rodriguez-Raecke R, Niemeier A, Ihle K, Ruether W, May A. Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J. Neurosci. 29(44), 13746-13750 (2009).
2. Blankstein U, Chen J, Diamant NE, Davis KD. Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors. Gastroenterology. 138(5), 1783-1789 (2010).
3. Baliki MN, Schnitzer TJ, Bauer WR, Apkarian AV. Brain morphological signatures for chronic pain. PLoS ONE 6(10), e26010 (2011).
4. Smallwood RF, Laird AR, Ramage AE et al. Structural brain anomalies and chronic pain: a quantitative meta-analysis of gray matter volume. J. Pain 14(7), 663-675 (2013).
5. Rekand T, Hagen EM, Gronning M. Chronic pain following spinal cord injury. Tidsskr. Nor. Laegeforen. 132(8), 974-979 (2012).
6. Klit H, Finnerup NB, Jensen TS. Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol. 8(9), 857-868 (2009).
7. Garcia-Larrea L, Perchet C, Creac'h C et al. Operculo-insular pain (parasylvian pain): a distinct central pain syndrome. Brain 133(9), 2528-2539 (2010).
8. Kim JS. Post-stroke pain. Expert Rev. Neurother. 9(5), 711-721 (2009).
9. Siddall PJ, McClelland JM, Rutkowski SB, Cousins MJ. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain 103(3), 249-257 (2003).
10. Borsook D. Neurological diseases and pain. Brain 135(Pt 2), 320-344 (2012).
11. Beiske AG, Loge JH, Ronningen A, Svensson E. Pain in Parkinson's disease: Prevalence and characteristics. Pain 141(1-2), 173-177 (2009).
12. Pillay PK, Hassenbusch SJ. Bilateral MRI-guided stereotactic cingulotomy for intractable pain. Stereotact. Funct. Neurosurg. 59(1-4), 33-38 (1992).
13. Jeanmonod D, Werner B, Morel A et al. Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain. Neurosurg. Focus 32(1), e1 (2012).
14. Solaro C, Trabucco E, Messmer Uccelli M. Pain and multiple sclerosis: pathophysiology and treatment. Curr. Neurol. Neurosci. Rep. 13(1), 320 (2013).
15. Ji R-R, Berta T, Nedergaard M. Glia and pain: is chronic pain a gliopathy? Pain doi:10.1016/j.pain.2013.06.022 (2013) (Epub ahead of print).
16. DeLeo JA, Tanga FY, Tawfik VL. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 10(1), 40-52 (2004).
17. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63(3), 289-302 (1995).
18. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect. Dis. 5(11), 718-725 (2005).
19. Agostini A, Benuzzi F, Filippini N et al. New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study. Neurogastroenterol. Motil. 25(2), 147-e82 (2013).
20. Teutsch S, Herken W, Bingel U, Schoell E, May A. Changes in brain gray matter due to repetitive painful stimulation. Neuroimage 42(2), 845-849 (2008).
21. Erpelding N, Moayedi M, Davis KD. Cortical thickness correlates of pain and temperature sensitivity. Pain 153(8), 1602-1609 (2012).
22. Erpelding N, Davis KD. Neural underpinnings of behavioural strategies that prioritize either cognitive task performance or pain. Pain 154(10), 2060-2071 (2013).
23. Moayedi M, Weissman-Fogel I, Crawley AP et al. Contribution of chronic pain and neuroticism to abnormal forebrain gray matter in patients with temporomandibular disorder. Neuroimage 55(1), 277-286 (2011).
24. Seminowicz DA, Wideman TH, Naso L et al. Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function. J. Neurosci. 31(20), 7540-7550 (2011).
25. Gwilym SE, Filippini N, Douaud G, Carr AJ, Tracey I. Thalamic atrophy associated with painful osteoarthritis of the hip is reversible after arthroplasty: a longitudinal voxel-based morphometric study. Arthritis Rheum. 62(10), 2930-2940 (2010).
26. Rodriguez-Raecke R, Niemeier A, Ihle K, Ruether W, May A. Structural brain changes in chronic pain reflect probably neither damage nor atrophy. PLoS ONE 8(2), e54475 (2013).
27. Sacher J, Neumann J, Funfstuck T, Soliman A, Villringer A, Schroeter ML. Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. J. Affect. Disord. 140(2), 142-148 (2012).
28. Du MY, Wu QZ, Yue Q et al. Voxelwise meta-analysis of gray matter reduction in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 36(1), 11-16 (2012).
29. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 104(3), 570-587 (2006).
30. Compton P, Charuvastra VC, Kintaudi K, Ling W. Pain responses in methadone-maintained opioid abusers. J. Pain Symptom Manage. 20(4), 237-245 (2000).
31. Peles E, Schreiber S, Hetzroni T, Adelson M, Defrin R. The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment. J. Pain 12(1), 41-50 (2011).
32. Diener HC, Katsarava Z. Medication overuse headache. Curr. Med. Res. Opin. 17 (SUPPL. 1), S17-S21 (2001).
33. Younger JW, Chu LF, D'Arcy NT, Trott KE, Jastrzab LE, Mackey SC. Prescription opioid analgesics rapidly change the human brain. Pain 152(8), 1803-10 (2011).
34. Upadhyay J, Maleki N, Potter J et al. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain 133(Pt 7), 2098-2114 (2010).
35. Tan TP, Algra PR, Valk J, Wolters EC. Toxic leukoencephalopathy after inhalation of poisoned heroin: MR findings. AJNR Am J Neuroradiol. 15(1), 175-178 (1994).
36. Offiah C, Hall E. Heroin-induced leukoencephalopathy: characterization using MRI, diffusion-weighted imaging, and MR spectroscopy. Clin. Radiol. 63(2), 146-152 (2008).
37. Shen Y, Wang E, Wang X, Lou M. Disrupted integrity of white matter in heroin-addicted subjects at different abstinent time. J. Addict. Med. 6(2), 172-176 (2012).
38. Cerase A, Leonini S, Bellini M, Chianese G , Venturi C. Methadone-induced toxic leukoencephalopathy: diagnosis and follow-up by magnetic resonance imaging including diffusion-weighted imaging and apparent diffusion coefficient maps. J. Neuroimaging 21(3), 283-286 (2011).
39. Salgado RA, Jorens PG, Baar I, Cras P, Hans G, Parizel PM. Methadone-induced toxic leukoencephalopathy: MR imaging and MR proton spectroscopy findings. AJNR Am. J. Neuroradiol. 31(3), 565-566 (2010).
40. Molloy S, Soh C, Williams TL. Reversible delayed posthypoxic leukoencephalopathy. AJNR Am. J. Neuroradiol. 27(8), 1763-1765 (2006).
41. Villella C, Iorio R, Conte G, Batocchi AP, Bria P. Toxic leukoencephalopathy after intravenous heroin injection: a case with clinical and radiological reversibility. J. Neurol. 257(11), 1924-1926 (2010).
42. Castren E. Neurotrophic effects of antidepressant drugs. Curr. Opin. Pharmacol. 4(1), 58-64 (2004).
43. Malberg JE, Blendy JA. Antidepressant action: to the nucleus and beyond. Trends Pharmacol. Sci. 26(12), 631-638 (2005).
44. Lagrue E, Chalon S, Bodard S, Saliba E, Gressens P, Castelnau P. Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice. Pediatr. Res. 62(1), 14-19 (2007).
45. Schmidt-Wilcke T, Leinisch E, Ganssbauer S et al. Affective components and intensity of pain correlate with structural differences in gray matter in chronic back pain patients. Pain 125(1-2), 89-97 (2006).
46. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 152(3 SUPPL.), S2-S15 (2011).
47. Borsook D, Kussman BD, George E, Becerra LR, Burke DW. Surgically induced neuropathic pain: understanding the perioperative process. Ann. Surg. 257(3), 403-12 (2013).
48. Zatorre RJ, Fields RD, Johansen-Berg H. Plasticity in gray and white: neuroimaging changes in brain structure during learning. Nat. Neurosci. 15(4), 528-536 (2012).
49. Driemeyer J, Boyke J, Gaser C, Buchel C, May A. Changes in gray matter induced by learning-revisited. PLoS ONE 3(7), e2669 (2008).
50. Bezzola L, Merillat S, Gaser C, Jancke L. Training-induced neural plasticity in golf novices. J. Neurosci. 31(35), 12444-12448 (2011).
51. Gaser C, Schlaug G. Brain structures differ between musicians and non-musicians. J. Neurosci. 23(27), 9240-9245 (2003).
52. Arenaza-Urquijo EM, Landeau B, La Joie R et al. Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders. Neuroimage doi:10.1016/j. neuroimage.2013.06.053 (2013) (E pub ahead of print).
53. Draganski B, Gaser C, Kempermann G et al. Temporal and spatial dynamics of brain structure changes during extensive learning. J. Neurosci. 26(23), 6314-6317 (2006).
54. Schmidt-Wilcke T, Rosengarth K, Luerding R, Bogdahn U, Greenlee MW. Distinct patterns of functional and structural neuroplasticity associated with learning Morse code. Neuroimage 51(3), 1234-1241 (2010).
55. Scholz J, Klein MC, Behrens TE, Johansen-Berg H. Training induces changes in white-matter architecture. Nat. Neurosci. 12(11), 1370-1371 (2009).
56. Gage FH. Neurogenesis in the adult brain. J. Neurosci. 22(3), 612-613 (2002).
57. May A, Hajak G, Ganssbauer S et al. Structural brain alterations following 5 days of intervention: dynamic aspects of neuroplasticity. Cereb. Cortex. 17(1), 205-210 (2007).
58. May A. Chronic pain may change the structure of the brain. Pain 137(1), 7-15 (2008).
59. Maleki N, Becerra L, Brawn J, Bigal M, Burstein R, Borsook D. Concurrent functional and structural cortical alterations in migraine. Cephalalgia 32(8), 607-620 (2012).
60. Maleki N, Becerra L, Brawn J, McEwen B, Burstein R, Borsook D. Common hippocampal structural and functional changes in migraine. Brain Struct. Funct. 218(4), 903-912 (2013).
61. Tu C-H, Niddam DM, Yeh T-C et al. Menstrual pain is associated with rapid structural alterations in the brain. Pain 154(9), 1718-1724 (2013).
62. DaSilva AF, Becerra L, Pendse G, Chizh B, Tully S, Borsook D. Colocalized structural and functional changes in the cortex of patients with trigeminal neuropathic pain. PLoS ONE 3(10), e3396 (2008).
63. Frokjaer JB, Bouwense SA, Olesen SS et al. Reduced cortical thickness of brain areas involved in pain processing in patients with chronic pancreatitis. Clin. Gastroenterol. Hepatol. 10(4), 434-438 e1 (2012).
64. Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J. Neurosci. 10(9), 2897-2902 (1990).
65. McEwen BS. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann. NY Acad. Sci. 933, 265-277 (2001).
66. Leverenz J, Wilkinson C, Wamble M et al. Effect of chronic high-dose exogenous cortisol on hippocampal neuronal number in aged nonhuman primates. J. Neurosci. 19(6), 2356-2361 (1999).
67. Vachon-Presseau E, Roy M, Martel M-O et al. The stress model of chronic pain: evidence from basal cortisol and hippocampal structure and function in humans. Brain 136(Pt 3), 815-827 (2013).
68. Bruehl H, Wolf OT, Convit A. A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology 34(6), 815-821 (2009).
69. Sorrells SF, Sapolsky RM. An inflammatory review of glucocorticoid actions in the CNS. Brain Behav. Immun. 21(3), 259-272 (2007).
70. Dinarello CA. Role of pro-and anti-inflammatory cytokines during inflammation: experimental and clinical findings. J. Biol .Regul. Homeost. Agents. 11(3), 91-103 (1997).
71. Bitzer-Quintero OK, Gonzalez-Burgos I. Immune system in the brain: a modulatory role on dendritic spine morphophysiology? Neural Plast. 2012, 348642 (2012).
72. Raivich G, Jones LL, Werner A, Bluthmann H, Doetschmann T, Kreutzberg GW. Molecular signals for glial activation: pro-and anti-inflammatory cytokines in the injured brain. Acta Neurochir. SUPPL. 73, 21-30 (1999).
73. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87(3), 873-904 (2007).
74. McEwen BS, Gianaros PJ. Stress-and allostasis-induced brain plasticity. Annu. Rev. Med. 62, 431-445 (2011).
75. Borsook D, Maleki N, Becerra L, McEwen B. Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load. Neuron 73(2), 219-234 (2012).
76. Imai S, Ikegami D, Yamashita A et al. Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain. Brain 136 (Pt 3), 828-843 (2013).
77. Del Rey A, Apkarian AV, Martina M, Besedovsky HO. Chronic neuropathic pain-like behavior and brain-borne IL-1b. Ann. NY Acad. Sci. 1262, 101-107 (2012).
78. Apkarian A V, Lavarello S, Randolf A et al. Expression of IL-1beta in supraspinal brain regions in rats with neuropathic pain. Neurosci. Lett. 407(2), 176-181 (2006).
79. Jiang C, Salton SR. The Role of Neurotrophins in Major Depressive Disorder. Transl. Neurosci. 4(1), 46-58 (2013).
80. Maya Vetencourt JF, Sale A, Viegi A et al. The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science 320(5874), 385-388 (2008).
81. Norrholm SD, Ouimet CC. Altered dendritic spine density in animal models of depression and in response to antidepressant treatment. Synapse 42(3), 151-163 (2001).
82. Liao D, Grigoriants OO, Wang W, Wiens K, Loh HH, Law PY. Distinct effects of individual opioids on the morphology of spines depend upon the internalization of mu opioid receptors. Mol. Cell. Neurosci. 35(3), 456-469 (2007).
83. Miller EC, Zhang L, Dummer BW et al. Differential modulation of drug-induced structural and functional plasticity of dendritic spines. Mol. Pharmacol. 82(2), 333-343 (2012).
84. McKinney RA. Excitatory amino acid involvement in dendritic spine formation, maintenance and remodelling. J. Physiol. 588(Pt 1), 107-116 (2010).
85. Hutton C, De Vita E, Ashburner J, Deichmann R, Turner R. Voxel-based cortical thickness measurements in MRI. Neuroimage 40(4), 1701-1710 (2008).
86. Takao H, Abe O, Ohtomo K. Computational analysis of cerebral cortex. Neuroradiology 52(8), 691-698 (2010).
87. Seminowicz DA, Laferriere AL, Millecamps M, Yu JSC, Coderre TJ, Bushnell MC. MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain. Neuroimage 47(3), 1007-1014 (2009).
88. Metz AE, Yau H-JJ, Centeno MV, Apkarian AV, Martina M. Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain. Proc. Natl Acad. Sci. USA 106(7), 2423-2428 (2009).
89. Kassem MS, Lagopoulos J, Stait-Gardner T et al. Stress-induced grey matter loss determined by MRI is primarily due to loss of dendrites and their synapses. Mol. Neurobiol. 47(2), 645-661 (2013).
90. Sato K. Disruption of spine homeostasis causes depression. Med. Hypotheses 81(1), 5-9 (2013).
91. Campbell JN, Register D, Churn SB. Traumatic brain injury causes an FK506-sensitive loss and an overgrowth of dendritic spines in rat forebrain. J. Neurotrauma 29(2), 201-217 (2012).
92. Nagerl U V, Eberhorn N, Cambridge SB, Bonhoeffer T. Bidirectional activity-dependent morphological plasticity in hippocampal neurons. Neuron 44(5), 759-767 (2004).
93. Segal M. Dendritic spines, synaptic plasticity and neuronal survival: activity shapes dendritic spines to enhance neuronal viability. Eur. J. Neurosci. 31(12), 2178-2184 (2010).
94. Auffret A, Gautheron V, Repici M et al. Age-dependent impairment of spine morphology and synaptic plasticity in hippocampal CA1 neurons of a presenilin 1 transgenic mouse model of Alzheimer's disease. J. Neurosci. 29(32), 10144-10152 (2009).
95. McLaughlin KJ, Baran SE, Conrad CD. Chronic stress-and sex-specific neuromorphological and functional changes in limbic structures. Mol. Neurobiol. 40(2), 166-182 (2009).
96. Mong JA, Glaser E, McCarthy MM. Gonadal steroids promote glial differentiation and alter neuronal morphology in the developing hypothalamus in a regionally specific manner. J. Neurosci. 19(4), 1464-1472 (1999).
97. Segev I, Rall W. Excitable dendrites and spines: earlier theoretical insights elucidate recent direct observations. Trends Neurosci. 21(11), 453-460 (1998).
98. Smith Y, Villalba RM, Raju D V. Striatal spine plasticity in Parkinson's disease: pathological or not? Parkinsonism Relat. Disord.15 SUPPL. 3, S156-S161 (2009).
99. Low AK, Ward K, Wines AP. Pediatric complex regional pain syndrome. J. Pediatr. Orthop. 27(5), 567-572 (2007).
100. Walco GA, Dworkin RH, Krane EJ, Le Bel AA, Treede RD. Neuropathic pain in children: Special considerations. Mayo Clin. Proc. 85(3 SUPPL.), S33-S41 (2010).
101. Duan H, Wearne SL, Rocher AB, Macedo A, Morrison JH, Hof PR. Age-related dendritic and spine changes in corticocortically projecting neurons in macaque monkeys. Cereb. Cortex. 13(9), 950-961 (2003).
102. Costigan M, Moss A, Latremoliere A et al. T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J. Neurosci. 29(46), 14415-14422 (2009).
103. Zehr JL, Nichols LR, Schulz KM, Sisk CL. Adolescent development of neuron structure in dentate gyrus granule cells of male Syrian hamsters. Dev. Neurobiol. 68(14), 1517-1526 (2008).
104. Zehr JL, Todd BJ, Schulz KM, McCarthy MM, Sisk CL. Dendritic pruning of the medial amygdala during pubertal development of the male Syrian hamster. J . Neurobiol. 66(6), 578-590 (2006).
105. Fillingim RB. Sex, gender, and pain: women and men really are different. Curr. Rev. Pain 4(1), 24-30 (2000).
106. Mayer EA, Berman S, Chang L, Naliboff BD. Sex-based differences in gastrointestinal pain. Eur. J. Pain. 8(5), 451-463 (2004).
107. Rustoen T, Wahl AK, Hanestad BR, Lerdal A, Paul S, Miaskowski C. Prevalence and characteristics of chronic pain in the general Norwegian population. Eur. J. Pain 8(6), 555-565 (2004).
108. Mendez P, Garcia-Segura LM, Muller D. Estradiol promotes spine growth and synapse formation without affecting pre-established networks. Hippocampus 21(12), 1263-1267 (2011).
109. Rasia-Filho AA, Dalpian F, Menezes IC, Brusco J, Moreira JE, Cohen RS. Dendritic spines of the medial amygdala: plasticity, density, shape, and subcellular modulation by sex steroids. Histol .Histopathol. 27(8), 985-1011 (2012).
110. Varlibas A, Erdemoglu AK. Altered trigeminal system excitability in menstrual migraine patients. J. Headache Pain 10(4), 277-282 (2009).
111. Lentz GM, Bavendam T, Stenchever MA, Miller JL, Smalldridge J. Hormonal manipulation in women with chronic, cyclic irritable bladder symptoms and pelvic pain. Am. J. Obstet. Gynecol. 186(6), 1263-1268 (2002).
112. Pinkerton J V, Guico-Pabia CJ, Taylor HS. Menstrual cycle-related exacerbation of disease. Am. J. Obstet. Gynecol. 202(3), 221-231 (2010).
113. Chen JR, Yan YT, Wang TJ, Chen LJ, Wang YJ, Tseng GF. Gonadal hormones modulate the dendritic spine densities of primary cortical pyramidal neurons in adult female rat. Cereb. Cortex. 19(11), 2719-2727 (2009).
114. Blackburn-Munro G, Blackburn-Munro RE. Chronic pain, chronic stress and depression: coincidence or consequence? J. Neuroendocrinol. 13(12), 1009-23 (2001).
115. McEwen BS, Kalia M. The role of corticosteroids and stress in chronic pain conditions. Metabolism 59 SUPPL. 1, S9-S15 (2010).
116. Yang G, Parkhurst CN, Hayes S, Gan WB. Peripheral elevation of TNF-alpha leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 110(25), 10306-10311 (2013).
117. Paolicelli RC, Bolasco G, Pagani F et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333(6048), 1456-1458 (2011).
118. Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 10(1), 23-36 (2009).
119. Kondo S, Kohsaka S, Okabe S. Long-term changes of spine dynamics and microglia after transient peripheral immune response triggered by LPS in vivo. Mol. Brain 4, 27 (2011).
120. Kasai K, Yamasue H, Gilbertson MW, Shenton ME, Rauch SL, Pitman RK. Evidence for acquired pregenual anterior cingulate gray matter loss from a twin study of combat-related posttraumatic stress disorder. Biol. Psychiatry 63(6), 550-556 (2008).
121. Shin LM, Bush G, Milad MR et al. Exaggerated activation of dorsal anterior cingulate cortex during cognitive interference: a monozygotic twin study of posttraumatic stress disorder. Am. J. Psychiatry. 168(9), 979-985 (2011).
122. Steinman L. Nuanced roles of cytokines in three major human brain disorders. J. Clin. Invest. 118(11), 3557-3563 (2008).
123. Slade GD, Conrad MS, Diatchenko L et al. Cytokine biomarkers and chronic pain: association of genes, transcription, and circulating proteins with temporomandibular disorders and widespread palpation tenderness. Pain 152(12), 2802-2812 (2011).
124. Sindrup SH, Otto M, Finnerup NB, Jensen TS. Antidepressants in the treatment of neuropathic pain. Basic Clin. Pharmacol. Toxicol. 96(6), 399-409 (2005).
125. Verdu B, Decosterd I, Buclin T, Stiefel F, Berney A. Antidepressants for the treatment of chronic pain. Drugs 68(18), 2611-2632 (2008).
126. Musazzi L, Treccani G, Mallei A, Popoli M. The action of antidepressants on the glutamate system: regulation of glutamate release and glutamate receptors. Biol. Psychiatry. 73(12), 1180-1188 (2013).
127. Jang SW, Liu X, Chan CB et al. Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity. Chem. Biol. 16(6), 644-656 (2009).
128. Spiga S, Puddu MC, Pisano M, Diana M. Morphine withdrawal-induced morphological changes in the nucleus accumbens. Eur. J. Neurosci. 22(9), 2332-2340 (2005).
129. Diana M, Spiga S, Acquas E. Persistent and reversible morphine withdrawal-induced morphological changes in the nucleus accumbens. Ann. NY Acad. Sci. 1074, 446-457 (2006).
130. Pal A, Das S. Chronic morphine exposure and its abstinence alters dendritic spine morphology and upregulates Shank1. Neurochem. Int. 62(7), 956-964 (2013).
131. Niesters M, Martini C, Dahan A. Ketamine for Chronic Pain: Risks and Benefits. Br. J. Clin. Pharmacol. (2013).
132. Li N, Liu RJ, Dwyer JM et al. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol. Psychiatry 69(8), 754-761 (2011).
133. Duman RS, Li N. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367(1601), 2475-2484 (2012).
134. Sun L, Li Q, Zhang Y et al. Chronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeys. Addict .Biol. (2012).
135. Ellingson BM, Mayer E, Harris RJ et al. Diffusion tensor imaging detects microstructural reorganization in the brain associated with chronic irritable bowel syndrome. Pain 154(9), 1528-1541 (2013).
136. Maeda Y, Kettner N, Sheehan J et al. Altered brain morphometry in carpal tunnel syndrome is associated with median nerve pathology. Neuroimage 2, 313-319 (2013).
137. Cesa R, Strata P. Activity-dependent axonal and synaptic plasticity in the cerebellum. Psychoneuroendocrinology 32 SUPPL. 1, S31-S35 (2007).
138. Golden SA, Christoffel DJ, Heshmati M et al. Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat. Med. 19(3), 337-344 (2013).
139. Hofer SB, Mrsic-Flogel TD, Bonhoeffer T, Hubener M. Experience leaves a lasting structural trace in cortical circuits. Nature 457(7227), 313-317 (2009).
140. Kim JB, Suh SI, Seo WK, Koh SB, Kim JH. Right Insular Atrophy in Neurocardiogenic Syncope: A Volumetric MRI Study. AJNR Am. J. Neuroradiol. (2013).
141. Taylor KS, Anastakis DJ, Davis KD. Cutting your nerve changes your brain. Brain 132(Pt 11), 3122-3133 (2009).
142. Schmidt-Wilcke T, Rosengarth K, Luerding R, Bogdahn U, Greenlee MW. Distinct patterns of functional and structural neuroplasticity associated with learning Morse code. Neuroimage 51(3), 1234-1241 (2010).
143. DaSilva AFM, Granziera C, Tuch DS, Snyder J, Vincent M, Hadjikhani N. Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine. Neuroreport 18(4), 301-305 (2007).
144. Valfre W, Rainero I, Bergui M, Pinessi L. Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache 48(1), 109-117 (2008).
145. Kim JH, Suh S-I, Seol HY et al. Regional grey matter changes in patients with migraine: a voxel-based morphometry study. Cephalalgia 28(6), 598-604 (2008).
146. Riederer F, Marti M, Luechinger R et al. Grey matter changes associated with medication-overuse headache: correlations with disease related disability and anxiety. World J. Biol. Psychiatry 13(7), 517-525 (2012).
147. Maleki N, Becerra L, Nutile L et al. Migraine attacks the Basal Ganglia. Mol. Pain 7, 71 (2011).
148. Maleki N, Becerra L, Brawn J, Bigal M, Burstein R, Borsook D. Concurrent functional and structural cortical alterations in migraine. Cephalalgia 32(8), 607-620 (2012).
149. Jin C, Yuan K, Zhao L et al. Structural and functional abnormalities in migraine patients without aura. NMR Biomed. 26(1), 58-64 (2013).
150. Younger JW, Shen YF, Goddard G, Mackey SC. Chronic myofascial temporomandibular pain is associated with neural abnormalities in the trigeminal and limbic systems. Pain 149(2), 222-228 (2010).
151. Gerstner G, Ichesco E, Quintero A, Schmidt-Wilcke T. Changes in regional gray and white matter volume in patients with myofascial-type temporomandibular disorders: a voxel-based morphometry study. J. Orofac. Pain 25(2), 99-106 (2011).
152. Moayedi M, Weissman-Fogel I, Crawley AP et al. Contribution of chronic pain and neuroticism to abnormal forebrain gray matter in patients with temporomandibular disorder. Neuroimage 55(1), 277-286 (2011).
153. Obermann M, Rodriguez-Raecke R, Naegel S et al. Gray matter volume reduction reflects chronic pain in trigeminal neuralgia. Neuroimage 74, 352-358 (2013).
154. DaSilva AF, Becerra L, Pendse G, Chizh B, Tully S, Borsook D. Colocalized structural and functional changes in the cortex of patients with trigeminal neuropathic pain. PLoS ONE 3(10), e3396 (2008).
155. Gustin SM, Peck CC, Wilcox SL, Nash PG, Murray GM, Henderson LA. Different pain, different brain: thalamic anatomy in neuropathic and non-neuropathic chronic pain syndromes. J. Neurosci. 31(16), 5956-5964 (2011).
156. Geha PY, Baliki MN, Harden RN, Bauer WR, Parrish TB, Apkarian AV. The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions. Neuron 60(4), 570-581 (2008).
157. Maeda Y, Kettner N, Sheehan J et al. Altered brain morphometry in carpal tunnel syndrome is associated with median nerve pathology. Neuroimage 2, 313-319 (2013).
158. Draganski B, Gaser C, Kempermann G et al. Temporal and spatial dynamics of brain structure changes during extensive learning. J. Neurosci. 26(23), 6314-6317 (2006).
159. Preißler S, Dietrich C, Blume KR, Hofmann GO, Miltner WHR, Weiss T. Plasticity in the Visual System is Associated with Prosthesis Use in Phantom Limb Pain. Front Hum. Neurosci. 7, 311 (2013).
160. Apkarian AV, Sosa Y, Sonty S et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J. Neurosci. 24(46), 10410-10415 (2004).
161. Schmidt-Wilcke T, Leinisch E, Ganssbauer S et al. Affective components and intensity of pain correlate with structural differences in gray matter in chronic back pain patients. Pain 125(1-2), 89-97 (2006).
162. Buckalew N, Haut MW, Morrow L, Weiner D. Chronic pain is associated with brain volume loss in older adults: preliminary evidence. Pain Med. 9(2), 240-248 (2008).
163. Seminowicz DA, Wideman TH, Naso L et al. Effective treatment of chronic low back pain in humans reverses abnormal brain anatomy and function. J. Neurosci. 31(20), 7540-7550 (2011).
164. Ivo R, Nicklas A, Dargel J et al. Brain structural and psychometric alterations in chronic low back pain. Eur. Spine J. (2013).
165. Schweinhardt P, Kuchinad A, Pukall CF, Bushnell MC. Increased gray matter density in young women with chronic vulvar pain. Pain 140(3), 411-419 (2008).
166. Farmer MA, Chanda ML, Parks EL, Baliki MN, Apkarian AV, Schaeffer AJ. Brain functional and anatomical changes in chronic prostatitis/chronic pelvic pain syndrome. J. Urol. 186(1), 117-124 (2011).
167. As-Sanie S, Harris RE, Napadow V et al. Changes in regional gray matter volume in women with chronic pelvic pain: a voxel-based morphometry study. Pain 153(5), 1006-1014 (2012).
168. Mordasini L, Weisstanner C, Rummel C et al. Chronic pelvic pain syndrome in men is associated with reduction of relative gray matter volume in the anterior cingulate cortex compared to healthy controls. J. Urol. 188(6), 2233-2237 (2012).
169. Rodriguez-Raecke R, Niemeier A, Ihle K, Ruether W, May A. Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J. Neurosci. 29(44), 13746-13750 (2009).
170. Gwilym SE, Filippini N, Douaud G, Carr AJ, Tracey I. Thalamic atrophy associated with painful osteoarthritis of the hip is reversible after arthroplasty: a longitudinal voxel-based morphometric study. Arthritis Rheum. 62(10), 2930-2940 (2010).
171. Kuchinad A, Schweinhardt P, Seminowicz DA, Wood PB, Chizh BA, Bushnell MC. Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain? J. Neurosci. 27(15), 4004-4007 (2007).
172. Burgmer M, Gaubitz M, Konrad C, et al. Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom. Med. 71(5), 566-573 (2009).
173. Robinson ME, Craggs JG, Price DD, Perlstein WM, Staud R. Gray matter volumes of pain-related brain areas are decreased in fibromyalgia syndrome. J. Pain 12(4), 436-443 (2011).
174. Blankstein U, Chen J, Diamant NE, Davis KD. Altered brain structure in irritable bowel syndrome: potential contributions of pre-existing and disease-driven factors. Gastroenterology 138(5), 1783-1789 (2010).
175. Seminowicz DA, Labus JS, Bueller JA et al. Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology 139(1), 48-57.e2 (2010).
176. Vartiainen N, Kallio-Laine K, Hlushchuk Y et al. Changes in brain function and morphology in patients with recurring herpes simplex virus infections and chronic pain. Pain 144(1-2), 200-208 (2009).
177. Upadhyay J, Maleki N, Potter J et al. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain 133(Pt 7), 2098-2114 (2010).
178. Younger JW, Chu LF, D'Arcy NT, Trott KE, Jastrzab LE, Mackey SC. Prescription opioid analgesics rapidly change the human brain. Pain 152(8), 1803-1810 (2011). Stroke